TMEM106A and astrocytoma (excluding glioblastoma): Taken together, TMEM106A serves as an independent prognostic factor and is associated with more aggressive glioma behavior, underscoring its potential prognostic utility, particularly in IDH‐wildtype astrocytomas (IDHwt).